At Lonza, I currently contribute to process validation as part of the MSAT team. I collaborate with cross-functional teams to support biopharmaceutical advancements.
Previously, I worked at Lonza as an MSAT Process Expert, applying my experience in process optimization and validation.
At University of Bern Internationals, I designed and synthesized peptide dendrimers, then tested them on human primary monocytes and PBMC to assess immunomodulatory properties and potential as a treatment for MS. Two candidates showed potential for immunotherapy, and I discovered a relationship between structure and activity.
At Frumkin Institute of Physical Chemistry & Electrochemistry, I developed fundamental research involving the synthesis of molecules with wide-ranging potential applications. My work across research and industry connects chemistry and molecular science with scalable solutions.
